美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Renaissance International IPO ETF

22.21

+0.11500.52%

成交量：251

成交額：5,578.49

市值：1,110.50萬

市盈率：- -

高：22.21

開：22.21

低：22.21

收：22.10

52周最高：26.25

52周最低：15.65

股本：50.00萬

流通股本：50.00萬

量比：1.30

換手率：0.05%

股息：0.14

股息率：0.65%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

觸及規範類退市！一A股公司將終止上市

官宣！千億光模塊廠商擬赴港IPO

澤璟製藥(688266.SH)：注射用人促甲狀腺素β新適應症上市申請獲得受理

美迪凱：91.805萬股預留授予第一類限制性股票將於9月10日上市流通

沈鼓集團(601091.SH)IPO定價4.39元/股 9月8日開啓申購

澤璟製藥：注射用人促甲狀腺素β新適應症上市申請獲受理

國內首款AI輔助創新藥獲批上市！西湖大學聯合研發僅用時三年半

我國首款AI輔助創新藥獲批上市

Kimi被傳秘密赴港IPO！引發行業關注

澤潤新能業績連降1年半去年上市募5.28億申萬宏源保薦

麒盛科技淨利連降2年半 2019上市募16.78億招商證券保薦

「滾開，煩不煩啊」，核心產品受試者試藥後死亡，知名生物公司董事受訪時怒懟記者，創始人是85後復旦女博士

覽富數據：A股IPO動態數據周報（截至2026年9月5日）

【圖片新聞】嘉峪關：梨香滿園採收忙

每日甘肃网

雲南省首款人工智能醫用軟件獲批上市

受試者試藥後死亡，知名生物公司董事怒懟記者：「滾開，煩不煩啊」，公司尚未有產品上市，正衝刺IPO

君樂寶被查出菌落超標！IPO遞表6天就遇到麻煩

27家上市城農商行中報掃描：25家實現淨利增長 15家淨息差按年下降

格雷博境外上市，證監會要求補充備案材料

宏鑫科技上半年轉虧 2024年上市募3.9億財通證券保薦

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/IPOS/news?page=49"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IPOS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPOS\",,,,,undefined,":{"symbol":"IPOS","market":"US","secType":"STK","nameCN":"Renaissance International IPO ETF","latestPrice":22.21,"timestamp":1789740583175,"preClose":22.095,"halted":0,"volume":251,"delay":0,"changeRate":0.00520479746549002,"floatShares":500001,"shares":500001,"eps":0,"marketStatus":"交易中","change":0.115,"latestTime":"09-18 10:12:02 EDT","open":22.205,"high":22.21,"low":22.205,"amount":5578.49006,"amplitude":0.000226,"askPrice":22.65,"askSize":100,"bidPrice":22.18,"bidSize":1,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789761600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":22.095,"sharesOutstanding":400001,"nav":22.174631,"aum":11087337.73,"dividendRate":0.006466,"bidAskSpread":0.005081,"postHourTrading":{"tag":"盘后","latestPrice":22.08,"preClose":22.095,"latestTime":"16:10 EDT","volume":7,"amount":154.665,"timestamp":1789675804188,"change":-0.015,"changeRate":-0.000679,"amplitude":0},"volumeRatio":1.296124,"impliedVol":0.8873,"impliedVolPercentile":0.9801},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPOS\",,,,,undefined,":{"symbol":"IPOS","floatShares":500001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.296124,"shares":500001,"dividePrice":0.1436,"high":22.21,"amplitude":0.000226,"preClose":22.095,"low":22.205,"week52Low":15.65,"pbRate":"--","week52High":26.25,"institutionHeld":0,"latestPrice":22.21,"committee":-0.980198,"eps":0,"divideRate":0.006466,"volume":251,"delay":0,"ttmEps":0,"open":22.205,"prevYearClose":16.8936,"prevWeekClose":22.665,"prevMonthClose":23.3188,"prevQuarterClose":25.635,"fiveDayClose":22.665,"twentyDayClose":23.2622,"sixtyDayClose":24.8672},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IPOS\",params:#limit:5,,,undefined,":[{"date":"2026-09-11","symbol":"IPOS","amount":0.072205,"announcedDate":"2026-09-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-11","defaultRemindTime":1789133400000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-11","currency":"USD","dateTimestamp":1789099200000,"payDate":"2026-09-18"},{"date":"2026-06-12","symbol":"IPOS","amount":0.054103,"announcedDate":"2026-06-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-12","defaultRemindTime":1781271000000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-22","payableDate":"2026-06-12","currency":"USD","dateTimestamp":1781236800000,"payDate":"2026-06-22"},{"date":"2025-12-12","symbol":"IPOS","amount":0.017941,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-19"},{"date":"2025-09-12","symbol":"IPOS","amount":0.007352,"announcedDate":"2025-09-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-12","defaultRemindTime":1757683800000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-12","currency":"USD","dateTimestamp":1757649600000,"payDate":"2025-09-19"},{"date":"2025-06-13","symbol":"IPOS","amount":0.13555,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-13","defaultRemindTime":1749821400000,"name":"Renaissance International IPO ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-13","currency":"USD","dateTimestamp":1749787200000,"payDate":"2025-06-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IPOS\",market:\"US\",,,undefined,":[{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.15245,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-22","value":0.05857,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-23","value":0.00775,"currency":"USD"},{"executeDate":"2018-06-15","recordDate":"2018-06-18","paymentDate":"2018-06-22","value":0.2024,"currency":"USD"},{"executeDate":"2018-12-14","recordDate":"2018-12-17","paymentDate":"2018-12-21","value":0.80265,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IPOS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IPOS\",pageSize:20,pageCount:49,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665364328","title":"觸及規範類退市！一A股公司將終止上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2665364328","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665364328?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 17:59","pubTimestamp":1788688740,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！9月6日，*ST萃华披露公告称，因公司未在被实施退市风险警示之日起两个月内披露过半数董事保证真实、准确、完整的2025年年度报告，根据规定，公司触及规范类退市情形，深交所将决定终止公司股票上市交易。公司股票9月7日起继续实施停牌。公告显示，深交所将在公司出现规范类终止上市情形后的规定期限内，作出是否终止公司股票上市的决定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2026-09-06/doc-iniqwsss4159324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["83188","399300","02827","159982","03130","02846","83130","BK1147","IPOS","03188","82846","07233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665364982","title":"官宣！千億光模塊廠商擬赴港IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2665364982","media":"维科网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665364982?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 16:57","pubTimestamp":1788685020,"startTime":"0","endTime":"0","summary":"光模块厂商光迅科技正式启动\"H+A\"双资本平台布局。此举标志着公司H股发行上市筹备工作进入实质性推进阶段。公司表示，报告期内全球AI算力投资持续升温，驱动数通光模块需求快速释放，公司重点产品中标份额保持领先。截至9月5日收盘，光迅科技报167.7元，总市值约1388亿元，较6月26日279元的高点回落约40%，当前市盈率仍高达约120倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-06/doc-iniqwssv0048906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AAOZ","BK4127","AAOG","KCE","LYTE","FRHC","IPOS","LUMA","AAOX","REDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665361627","title":"澤璟製藥(688266.SH)：注射用人促甲狀腺素β新適應症上市申請獲得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2665361627","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665361627?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 15:36","pubTimestamp":1788680173,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泽璟制药(688266.SH)发布公告，近日，公司收到国家药品监督管理局核准签发的《受理通知书》，公司递交的注射用人促甲状腺素β(曾用名：注射用重组人促甲状腺激素，商标：泽速宁®)新适应症上市申请获得受理，本次获得受理的适应症是用于无远处转移的分化型甲状腺癌患者甲状腺全切或近全切除术后协同放射性碘(131I)清除残余甲状腺组织的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492461.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1574","688266","IPOS","01477","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665336162","title":"美迪凱：91.805萬股預留授予第一類限制性股票將於9月10日上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2665336162","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665336162?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 15:35","pubTimestamp":1788680127,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665361625","title":"沈鼓集團(601091.SH)IPO定價4.39元/股 9月8日開啓申購","url":"https://stock-news.laohu8.com/highlight/detail?id=2665361625","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665361625?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 15:33","pubTimestamp":1788680038,"startTime":"0","endTime":"0","summary":"智通财经APP讯，沈鼓集团(601091.SH)发布公告，公司确定本次发行价格为4.39元/股，网下发行不再进行累计投标询价。投资者请按此价格在2026年9月8日(T日)进行网上和网下申购，申购时无需缴付申购资金。其中，网下申购时间为9:30-15:00，网上申购时间为9:30-11:30、13:00-15:00。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492460.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["601091","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665361649","title":"澤璟製藥：注射用人促甲狀腺素β新適應症上市申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2665361649","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665361649?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 15:32","pubTimestamp":1788679962,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665403361","title":"國內首款AI輔助創新藥獲批上市！西湖大學聯合研發 僅用時三年半","url":"https://stock-news.laohu8.com/highlight/detail?id=2665403361","media":"快科技","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665403361?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 15:30","pubTimestamp":1788679839,"startTime":"0","endTime":"0","summary":"快科技9月6日消息，据西湖大学微信公众号消息，近期，由西湖大学、西湖实验室、西湖制药联合研发的创新药——盐酸伊司特韦片 正式获得国家药品监督管理局附条件批准上市。据悉，它是国内首款凭借AI辅助研发而获批上市的原创药——从源头发现到完成临床试验，仅用时三年半。这也是西湖大学首款完全自主研发的1类创新药，用于成人轻型、中型新型冠状病毒感染的治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8wCSabf9QIo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["AIPO","BK1574","IPOS","BK1161","06978","CHAT","LNGR","MEDX","ARTY","159992","QTOC","VTHR","AGIX","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665361592","title":"我國首款AI輔助創新藥獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2665361592","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665361592?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 15:04","pubTimestamp":1788678281,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS","LNGR","MEDX","VTHR","AIPO","CHAT","ARTY","IBBQ","QTOC","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665362587","title":"Kimi被傳秘密赴港IPO！引發行業關注","url":"https://stock-news.laohu8.com/highlight/detail?id=2665362587","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665362587?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 14:53","pubTimestamp":1788677580,"startTime":"0","endTime":"0","summary":"9月2日，据知名媒体《晚点LatePost》消息，Kimi背后的母公司月之暗面已以保密形式向港交所递交A1文件。而同期Anthropic的ARR预计约620亿美元、OpenAI约435亿美元。在这一点上，Kimi的收入曲线正在接近Anthropic早期商业化阶段的特征。K3发布后，用户请求量大幅超出预估，48小时内逼近现有集群承载极限。第二天，MiniMax以165港元挂牌。MiniMax收入同比增长283.1%，毛利率从12.1%升至17.9%，经调整净亏损仍达2.9亿美元。2025年，国内AI大模型行业整体亏损约180亿元，中金预测202","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-09-06/doc-iniqxchv1068740.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["FRHC","KCE","IPOS","REDS","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665131369","title":"澤潤新能業績連降1年半 去年上市募5.28億申萬宏源保薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2665131369","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665131369?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 11:26","pubTimestamp":1788665163,"startTime":"0","endTime":"0","summary":"中国经济网北京9月6日讯 泽润新能 近日披露2026年半年度报告。　　2026年1-6月，公司实现营业收入4.05亿元，同比下降9.83%；归属于上市公司股东的净利润873.81万元，同比下降84.62%；归属于上市公司股东的扣除非经常性损益的净利润419.12万元，同比下降91.75%；经营活动产生的现金流量净额-6,726.23万元，上年同期为-9,582.72万元。　　泽润新能本次发行费用合计为6,569.62万元，其中，保荐承销费用为3,655.73万元。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/06/20260906919734.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/06/20260906919734.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260906/32361217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0183","BK0028","BK0224","BK1564","000166","IPOS","06806","BK0188","BK0276","BK1147","BK0012","301636"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665699763","title":"麒盛科技淨利連降2年半 2019上市募16.78億招商證券保薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2665699763","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665699763?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 11:26","pubTimestamp":1788665162,"startTime":"0","endTime":"0","summary":"中国经济网北京9月6日讯 麒盛科技 近日披露2026年半年度报告。　　麒盛科技发行费用合计8228.33万元，其中，招商证券获得保荐及承销费用6330万元、天健会计师事务所获得审计费用与验资费用1080万元、上海市锦天城律师事务所获得律师费用300万元。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/06/20260906643838.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/06/20260906643838.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260906/32361214.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0260","600999","06099","IPOS","603610","BK0188","BK0028","BK0276","BK1564","BK1147","BK0010","BK0183","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665694523","title":"「滾開，煩不煩啊」，核心產品受試者試藥後死亡，知名生物公司董事受訪時怒懟記者，創始人是85後復旦女博士","url":"https://stock-news.laohu8.com/highlight/detail?id=2665694523","media":"市场资讯","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665694523?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 10:28","pubTimestamp":1788661680,"startTime":"0","endTime":"0","summary":"“滚开，烦不烦啊”，核心产品受试者试药后死亡，知名生物公司董事受访时怒怼记者，创始人是85后复旦女博士，公司正冲刺IPO，已连亏2年半来源：第一财经，医健趋势，药械出海受试者死亡事件曝光后，易慕峰的对外沟通方式再添争议。这起受试者死亡事件，恰逢易慕峰冲刺港股IPO的关键节点，将这家尚无产品上市的生物科技企业推向舆论风口。招股书显示，易慕峰创始人孙敏敏现年40岁，她拥有复旦大学药学博士学位。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-06/doc-iniqwhav9495071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00B7SZL793.SGD","IE00B19Z4B17.USD","IE00B66KJ199.SGD","BK4006","BK4022","BK4187","IPOS","LU2065731478.USD","BK4230","CRS","IE0031619046.USD","CAR","LU0963586101.USD","PYZ","XAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665693583","title":"覽富數據：A股IPO動態數據周報（截至2026年9月5日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2665693583","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665693583?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 09:40","pubTimestamp":1788658801,"startTime":"0","endTime":"0","summary":"览富财经网统计，2026年8月31日-2026年9月5日，3家企业首发上会获通过，3家企业提交注册，1家企业拿文，5家企业成功上市。下周首发上会企业2家。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/06/20260906783144.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/06/20260906783144.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260906/32361186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["07233","399300","KCE","REDS","03130","02846","FRHC","83188","159982","03188","IPOS","82846","BK1147","BK4127","02827","83130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665369862","title":"【圖片新聞】嘉峪關：梨香滿園採收忙","url":"https://stock-news.laohu8.com/highlight/detail?id=2665369862","media":"每日甘肃网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665369862?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 09:20","pubTimestamp":1788657600,"startTime":"0","endTime":"0","summary":"图片新闻近日，嘉峪关市文殊镇石桥村300亩早酥梨成熟上市，果农抓紧采收。新甘肃·甘肃日报通讯员 马玉福责任编辑：宋菲菲","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-06/doc-iniqvvpf0300445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665366766","title":"雲南省首款人工智能醫用軟件獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2665366766","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665366766?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 08:11","pubTimestamp":1788653463,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["VGT","NAPR","NEWZ","MVPS","TECY","PBOT","AIBU","NJAN","QSWN","IPOS","02834","TQQY","DQJN","KOMP","TQQQ","MFIG","AQGX","NBDS","QID","AIFD","QLD","LCLG","TARK","AIQU","GPIQ","09086","PSQ","NOCT","03086","03455","OGIG","WPAI","QQQM","CWC","NJUL","QTOC","ARTY","AGIX","GK","CHAT","QMAR","FWD","VUSE","QDEC","QQA","SQQQ","CPNQ","QQQX","QQQ","03034"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665636677","title":"受試者試藥後死亡，知名生物公司董事怒懟記者：「滾開，煩不煩啊」，公司尚未有產品上市，正衝刺IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2665636677","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665636677?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 08:11","pubTimestamp":1788653460,"startTime":"0","endTime":"0","summary":"受试者试药后死亡，知名生物公司董事怒怼记者：“滚开，烦不烦啊”，公司尚未有产品上市，正冲刺IPO，两年半亏损近3亿元来源：中国经济网近日，多家媒体报道称，一名男子在加入深圳易慕峰生物科技股份有限公司一项名为IMC002的CAR-T细胞临床试验后离世。这起受试者死亡事件，恰逢易慕峰冲刺港股IPO的关键节点，将这家尚无产品上市的生物科技企业推向舆论风口。术后占某长期昏迷，于2026年4月26日在上海长海医院ICU去世。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-06/doc-iniqvvnz9680343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4127","REDS","KCE","FRHC","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665369694","title":"君樂寶被查出菌落超標！IPO遞表6天就遇到麻煩","url":"https://stock-news.laohu8.com/highlight/detail?id=2665369694","media":"市场资讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665369694?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 00:22","pubTimestamp":1788625320,"startTime":"0","endTime":"0","summary":"8月20日，君乐宝乳业向港交所递交了更新后的IPO申报材料。声明深表歉意，并承诺全面加强全流程质量管控。站在资本市场视角，这类未流入市场的境外食安通报，几乎必然触发港交所对君乐宝全链路品控的针对性问询，拉长IPO审核周期。截至2026年6月末，君乐宝资产负债率达76.57%，虽然较2025年末的80.31%有所下降，远高于行业头部企业。而君乐宝的应对之策，是去港股IPO融资。据弗若斯特沙利文数据，2025年君乐宝低温液奶市场份额达15.6%，位居全国第一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkstocknews/2026-09-06/doc-iniqvzve6995844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS","KCE","FRHC","REDS","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665363161","title":"27家上市城農商行中報掃描：25家實現淨利增長 15家淨息差按年下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2665363161","media":"澎湃新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665363161?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 21:32","pubTimestamp":1788615120,"startTime":"0","endTime":"0","summary":"随着2026年半年报披露收官，A股27家上市城商行、农商行上半年业绩情况已全部出炉。整体来看，上市城农商行上半年盈利保持增长，27家银行中有25家归母净利润实现同比增长，平均增速为5.23%。不过，营收表现分化较为明显，平均增速为5.37%。与此同时，上市城农商行资产规模总体保持扩张；净息差整体承压，但部分银行已经出现回升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609053866037893.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609053866037893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IYG","BK4535","FTXO","UYG","BK4588","IPOS","PBEU","FAS","BCFN","QABA","GABF","JHMF","IEFN","BK4585","XLFX","KBWB","HSBH","FYLG","FINY","BNKO","FNCL","VFH","KBWD","KRE","KNAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665680203","title":"格雷博境外上市，證監會要求補充備案材料","url":"https://stock-news.laohu8.com/highlight/detail?id=2665680203","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665680203?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 18:30","pubTimestamp":1788604200,"startTime":"0","endTime":"0","summary":"本文源自：市场资讯证监会国际司日前对5家拟境外发行上市企业备案提出补充材料要求，格雷博智能动力科技股份有限公司在列。证监会国际司还要求格雷博补充说明公司国有股东履行国有股标识等国资管理程序进展情况，以及就股份“全流通”履行的审批或内部决策程序的情况。据新浪财经报道，格雷博于9月4日收到中国证监会国际部关于本次境外上市的备案反馈意见，监管要求律师进行核查并出具明确法律意见。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2026-09-05/doc-iniqupts5094031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665468368","title":"宏鑫科技上半年轉虧 2024年上市募3.9億財通證券保薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2665468368","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665468368?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 16:55","pubTimestamp":1788598504,"startTime":"0","endTime":"0","summary":"中国经济网北京9月5日讯 宏鑫科技 2026年半年度报告显示，公司上半年实现营业收入6.38亿元，同比增长27.32%；归属于上市公司股东的净利润-0.18亿元，上年同期为0.28亿元；归属于上市公司股东的扣除非经常性损益的净利润-0.21亿元，上年同期为0.25亿元；经营活动产生的现金流量净额-0.16亿元，上年同期为-0.11亿元。　　宏鑫科技本次发行费用总额为8,648.00万元，其中保荐及承销费用4,528.30万元。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/05/20260905506673.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/05/20260905506673.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260905/32361085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301539","IPOS","BK0276","BK0264","601108"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":51,"pageCount":49,"totalSize":1012,"code":"91000000","status":"200"}]}}